These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9332464)

  • 41. [Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo].
    Zhou Y; Chen H; Yang Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):25-8. PubMed ID: 8758815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.
    Kamazawa S; Kigawa J; Minagawa Y; Itamochi H; Shimada M; Takahashi M; Sato S; Akeshima R; Terakawa N
    Oncology; 2000 Nov; 59(4):329-35. PubMed ID: 11096346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer.
    Falcetta F; Bizzaro F; D'Agostini E; Bani MR; Giavazzi R; Ubezio P
    Cancer Res; 2017 Dec; 77(23):6759-6769. PubMed ID: 28951463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers.
    He H; Yu T; Zhang Y
    Ultraschall Med; 2012 Jun; 33(3):275-82. PubMed ID: 21165815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
    Smith JA; Ngo H; Martin MC; Wolf JK
    Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
    Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
    Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants.
    Woolley DE; Tetlow LC; Adlam DJ; Gearey D; Eden RD; Ward TH; Allen TD
    Exp Cell Res; 2002 Feb; 273(1):65-72. PubMed ID: 11795947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines.
    McClay EF; Albright KD; Jones JA; Christen RD; Howell SB
    Br J Cancer; 1994 Sep; 70(3):449-52. PubMed ID: 8080729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.
    Schiano MA; Sevin BU; Perras J; Ramos R; Wolloch EH; Averette HE
    Gynecol Oncol; 1991 Oct; 43(1):37-45. PubMed ID: 1959786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
    Jekunen AP; Christen RD; Shalinsky DR; Howell SB
    Br J Cancer; 1994 Feb; 69(2):299-306. PubMed ID: 7905279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer.
    Yang J; Ju Z; Dong S
    Drug Deliv; 2016 Nov; 24(1):792-799. PubMed ID: 28494629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of yondelis and cisplatin is synergistic against human tumor xenografts.
    D'Incalci M; Colombo T; Ubezio P; Nicoletti I; Giavazzi R; Erba E; Ferrarese L; Meco D; Riccardi R; Sessa C; Cavallini E; Jimeno J; Faircloth GT
    Eur J Cancer; 2003 Sep; 39(13):1920-6. PubMed ID: 12932672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation.
    Wilkins DE; Ng CE; Raaphorst GP
    Cancer Chemother Pharmacol; 1997; 40(2):159-66. PubMed ID: 9182838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models.
    Oliva P; Decio A; Castiglioni V; Bassi A; Pesenti E; Cesca M; Scanziani E; Belotti D; Giavazzi R
    Br J Cancer; 2012 Jul; 107(2):360-9. PubMed ID: 22713663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
    Klaassen U; Harstrick A; Schleucher N; Vanhoefer U; Schröder J; Wilke H; Seeber S
    Br J Cancer; 1996 Jul; 74(2):224-8. PubMed ID: 8688325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
    Engblom P; Rantanen V; Kulmala J; Helenius H; Grènman S
    Br J Cancer; 1999 Jan; 79(2):286-92. PubMed ID: 9888470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.
    Ercoli A; Battaglia A; Raspaglio G; Fattorossi A; Alimonti A; Petrucci F; Caroli S; Mancuso S; Scambia G
    Int J Cancer; 2000 Jan; 85(1):98-103. PubMed ID: 10585591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The combination of paclitaxel with cisplatin exhibits antagonism in vitro against human melanoma.
    Mohith A; Photiou A; Retsas S
    Anticancer Drugs; 1996 Jun; 7(4):493-8. PubMed ID: 8826619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.